Teijin Pharma Starts to Exclusive Sales of Transcranial Magnetic Stimulation Device in Japan - BioSpace

Submitted by Anonymous (not verified) on Thu, 06/06/2019 - 08:46

Teijin Pharma Starts to Exclusive Sales of Transcranial Magnetic Stimulation Device in Japan  BioSpacePublished: Jun 05, 2019. Tokyo, Japan, June 5, 2019 --- Teijin Pharma Limited, the core company of the Teijin Group's healthcare business, announced today ...